(NYSE: EW) Edwards Lifesciences's forecast annual revenue growth rate of 9.47% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.
Edwards Lifesciences's revenue in 2025 is $5,439,500,000.On average, 12 Wall Street analysts forecast EW's revenue for 2025 to be $3,461,116,038,700, with the lowest EW revenue forecast at $3,406,457,212,000, and the highest EW revenue forecast at $3,504,476,015,300. On average, 12 Wall Street analysts forecast EW's revenue for 2026 to be $3,802,925,801,900, with the lowest EW revenue forecast at $3,725,522,300,000, and the highest EW revenue forecast at $3,859,445,920,000.
In 2027, EW is forecast to generate $4,210,826,695,200 in revenue, with the lowest revenue forecast at $4,067,680,100,000 and the highest revenue forecast at $4,316,067,850,000.